ASOC: Driving Medical Policy Changes


The new report, ASOC: Driving Medical Policy Changes, briefly explores the shift to alternate sites of care (ASOC), the underlying issues, and resulting implications for key stakeholders around the use of biologic and specialty infusion drugs.

This report takes a brief look at the strategies and new policies of payers and PBMs as they look to lower the cost of specialty drugs and compete successfully in an evolving market and the resulting impact on key industry stakeholders.